Detalhe da pesquisa
1.
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Front Oncol
; 10: 202, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32211314
2.
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients.
Oncoimmunology
; 7(12): e1465163, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30524882
3.
Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins.
J Mol Histol
; 38(3): 215-26, 2007 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-17476578
4.
Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat.
J Mol Histol
; 36(1-2): 59-67, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15704000
5.
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.
Cancer Res
; 70(18): 7084-92, 2010 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20823160